CanFite Bio CANF Future Outlook CANF Q4 2023 Earnings CanFite Biopharma Posts 962 EPS Beat 405B Revenue National NGG Stock Market Catalysts Overview Institutional Selling 20260418 McEwen MUX Economic Sensitivity Q4 2025 Earnings Beat Estimates Why investors are rethinking Valaris VAL Dormant 20260506 Morgan Stanley MS Cuts iQIYI IQ Financial Projections and Price Target Amid NearTerm Operating Headwinds What separates Pantages PGACR from the pack 1266 20260506 Why Ferguson Enterprises FERG Just Dropped 260 What to Watch 20260515 Jim Cramer Bond Markets Wrath Could Smack Down Stocks Amid Rising Yields and Oil Surge Fed Chair Powell at Crossroads Decision Looms as Criminal Investigation Concludes Yunhong Green CTI Ltd YHGJ Hovers Near Support Amid Modest Decline Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Over Security Risks BLDP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Movement DOJ Charges Google Employee with Insider Trading on Polymarket Prediction Markets Quantum Computing Stocks Rally on US Governments 2 Billion Funding Plan and Equity Stake Proposal UK Police to Assess Train Operators on Sexual Harassment Prevention No Financial Penalties Imposed HYNE Q1 2026 Earnings Narrowing Losses Amid Quiet Quarter Harvard Endowment Faces Private Equity Hangover as Succession Looms for Narvekar CorVel Q4 2026 Earnings Call Transcript Released Management Discusses Quarterly Performance and Strategic Direction HFBL Q3 2025 Earnings EPS of 024 Amid a Challenging Rate Environment REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Awaits Clinical Milestones